ICD-10-CM Billable Code

E34.5

Androgen insensitivity syndrome

Clinical Classification Guidelines

Medical Intelligence & Overview

Androgen Insensitivity Syndrome (AIS) is a rare genetic condition affecting sexual development in individuals with an XY chromosome pattern, typically male. In AIS, the body's cells are unable to respond properly to androgens, which are hormones responsible for male traits and sexual development. As a result, individuals with AIS may develop physical characteristics that are not typical for their genetic sex, often leading to unique reproductive and physical features. The condition can vary significantly between individuals, with some showing almost complete resistance to androgens and others experiencing partial responses, leading to a spectrum of physical and health-related features.

Causes & Symptoms

Clinical Causes: Genetic mutation in the AR gene responsible for androgen receptors Inheritance pattern is typically X-linked recessive, meaning the gene responsible is located on the X chromosome Inheritances from carrier mothers who carry the mutation but do not show symptoms No environmental factors have been conclusively linked to the development of AIS

Key Symptoms: Undescended testes or absence of testes in the scrotum Vaginal opening may be small or absent Swelling of the labia may resemble scrotal tissue Absence of typical male secondary sexual characteristics such as beard growth, voice deepening, and pubic hair Developed breast tissue during puberty due to estrogen influence Short or absent uterine and fallopian tube formation, leading to infertility Normal or nearly normal external female genitalia despite XY chromosomes In some cases, individuals may present with ambiguous genitalia at birth

Diagnostic & Treatment

Diagnosis Path: Diagnosis of AIS generally involves a combination of physical examinations, medical history, and laboratory tests. These include: - Karyotype analysis to identify XY chromosome pattern - Hormone level testing to assess levels of testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) - Pelvic ultrasound or MRI to evaluate internal reproductive organs - Genetic testing to identify mutations in the AR gene - Occasionally, biopsies or exploratory surgery may be conducted to assess internal structures Diagnosis typically occurs during adolescence or adulthood when primary or secondary sexual characteristics do not develop as expected or when infertility is investigated.

Treatment Protocols: While there is no cure for AIS, management focuses on addressing associated medical and psychological needs. Treatment options can include: - Hormone replacement therapy (HRT) to develop secondary sexual characteristics or maintain bone health - Surgical intervention to remove undescended testes if necessary, due to potential cancer risk - Psychological counseling and support to address social, emotional, and reproductive concerns - Education and support for individuals and families to understand the condition - Fertility options are limited, but adoption or assisted reproductive technologies may be explored It is important that treatment plans are tailored to each individual's needs and that management is coordinated by a team of specialists experienced in disorders of sexual development.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E34.5 a billable ICD-10 code?
Yes, E34.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E34.5?
Clinical documentation must specify the nature of Androgen insensitivity syndrome and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

androgen insensitivity syndrome